Molecular Partners AG
MOLN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $82 | $82 | $81 | $64 |
| Short-Term Investments | $22 | $33 | $50 | $86 |
| Receivables | $2 | $4 | $4 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $5 |
| Total Curr. Assets | $109 | $121 | $137 | $154 |
| Property Plant & Equip (Net) | $3 | $4 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $4 | $4 | $4 |
| Other Assets | $0 | -$0 | $0 | $0 |
| Total Assets | $112 | $124 | $141 | $159 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $2 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $10 | $5 | $9 |
| Total Curr. Liab. | $12 | $13 | $9 | $11 |
| LT Debt | $0 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $4 | $3 | $5 |
| Total NC Liab. | $5 | $5 | $4 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $17 | $18 | $13 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $4 | $4 |
| Retained Earnings | -$296 | -$283 | -$261 | -$246 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $387 | $386 | $385 | $384 |
| Total Equity | $96 | $107 | $128 | $142 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $112 | $124 | $141 | $159 |
| Net Debt | -$81 | -$80 | -$79 | -$61 |